APO Research

APO RESEARCH · REPORT

Sevoflurane Vaporizer

Selected research

Industry Growth & Trends

Global Sevoflurane Vaporizer Industry Growth and Trends Forecast to 2032

Market perspective

The global Sevoflurane Vaporizer market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sevoflurane Vaporizer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sevoflurane Vaporizer is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sevoflurane Vaporizer is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sevoflurane Vaporizer include Dräger, GE Healthcare, Mindray, Spacelabs Healthcare, Maquet, Baxter, Oricare, STEPHAN and Medec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sevoflurane Vaporizer market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sevoflurane Vaporizer market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sevoflurane Vaporizer market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sevoflurane Vaporizer.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sevoflurane Vaporizer market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sevoflurane Vaporizer Market by Company

Dräger

GE Healthcare

Mindray

Spacelabs Healthcare

Maquet

Baxter

Oricare

STEPHAN

Medec

Foshan Gladent

Hersill

Dragerwerk

Penlon

Nipro

Sevoflurane Vaporizer Segment by Type

Active Temperature Compensation

Passive Temperature Compensation

Sevoflurane Vaporizer Segment by Application

Surgical Anesthesia

Medical Research

Animal Anesthesia

Others

Sevoflurane Vaporizer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane Vaporizer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane Vaporizer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane Vaporizer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sevoflurane Vaporizer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sevoflurane Vaporizer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Active Temperature Compensation Table 2. Major Company of Passive Temperature Compensation Table 3. Global Sevoflurane Vaporizer Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Sevoflurane Vaporizer Sales by Type (2021-2026) & (units) Table 5. Global Sevoflurane Vaporizer Sales Market Share in Volume by Type (2021-2026) Table 6. Global Sevoflurane Vaporizer Sales by Type (2021-2026) & (US$ Million) Table 7. Global Sevoflurane Vaporizer Sales Market Share in Value by Type (2021-2026) Table 8. Global Sevoflurane Vaporizer Price by Type (2021-2026) & (USD/unit) Table 9. Global Sevoflurane Vaporizer Sales by Type (2027-2032) & (units) Table 10. Global Sevoflurane Vaporizer Sales Market Share in Volume by Type (2027-2032) Table 11. Global Sevoflurane Vaporizer Sales by Type (2027-2032) & (US$ Million) Table 12. Global Sevoflurane Vaporizer Sales Market Share in Value by Type (2027-2032) Table 13. Global Sevoflurane Vaporizer Price by Type (2027-2032) & (USD/unit) Table 14. North America Sevoflurane Vaporizer Sales by Type (2021-2026) & (units) Table 15. North America Sevoflurane Vaporizer Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Sevoflurane Vaporizer Sales by Type (2021-2026) & (units) Table 17. Europe Sevoflurane Vaporizer Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Sevoflurane Vaporizer Sales by Type (2021-2026) & (units) Table 19. Asia-Pacific Sevoflurane Vaporizer Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Sevoflurane Vaporizer Sales by Type (2021-2026) & (units) Table 21. Latin America Sevoflurane Vaporizer Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Sevoflurane Vaporizer Sales by Type (2021-2026) & (units) Table 23. Middle East and Africa Sevoflurane Vaporizer Sales by Type (2021-2026) & (US$ Million) Table 24. Sevoflurane Vaporizer Industry Trends Table 25. Sevoflurane Vaporizer Industry Drivers Table 26. Sevoflurane Vaporizer Industry Opportunities and Challenges Table 27. Sevoflurane Vaporizer Industry Restraints Table 28. Global Sevoflurane Vaporizer Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Sevoflurane Vaporizer Revenue Market Share by Company (2021-2026) Table 30. Global Sevoflurane Vaporizer Sales by Company (2021-2026) & (units) Table 31. Global Sevoflurane Vaporizer Sales Share by Company (2021-2026) Table 32. Global Sevoflurane Vaporizer Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Sevoflurane Vaporizer Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Sevoflurane Vaporizer Major Company Production Sites and Headquarters Table 35. Global Sevoflurane Vaporizer Company, Product Type & Application Table 36. Global Sevoflurane Vaporizer Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Sevoflurane Vaporizer by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Sevoflurane Vaporizer Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Sevoflurane Vaporizer Sales by Region (2021-2026) & (units) Table 41. Global Sevoflurane Vaporizer Sales Market Share in Volume by Region (2021-2026) Table 42. Global Sevoflurane Vaporizer Sales by Region (2021-2026) & (US$ Million) Table 43. Global Sevoflurane Vaporizer Sales Market Share in Value by Region (2021-2026) Table 44. Global Sevoflurane Vaporizer Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Sevoflurane Vaporizer Sales by Region (2027-2032) & (units) Table 46. Global Sevoflurane Vaporizer Sales Market Share in Volume by Region (2027-2032) Table 47. Global Sevoflurane Vaporizer Sales by Region (2027-2032) & (US$ Million) Table 48. Global Sevoflurane Vaporizer Sales Market Share in Value by Region (2027-2032) Table 49. Global Sevoflurane Vaporizer Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Sevoflurane Vaporizer Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Sevoflurane Vaporizer Sales by Application (2021-2026) & (units) Table 52. Global Sevoflurane Vaporizer Sales Market Share in Volume by Application (2021-2026) Table 53. Global Sevoflurane Vaporizer Sales by Application (2021-2026) & (US$ Million) Table 54. Global Sevoflurane Vaporizer Sales Market Share in Value by Application (2021-2026) Table 55. Global Sevoflurane Vaporizer Price by Application (2021-2026) & (USD/unit) Table 56. Global Sevoflurane Vaporizer Sales by Application (2027-2032) & (units) Table 57. Global Sevoflurane Vaporizer Sales Market Share in Volume by Application (2027-2032) Table 58. Global Sevoflurane Vaporizer Sales by Application (2027-2032) & (US$ Million) Table 59. Global Sevoflurane Vaporizer Sales Market Share in Value by Application (2027-2032) Table 60. Global Sevoflurane Vaporizer Price by Application (2027-2032) & (USD/unit) Table 61. North America Sevoflurane Vaporizer Sales by Application (2021-2026) & (units) Table 62. North America Sevoflurane Vaporizer Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Sevoflurane Vaporizer Sales by Application (2021-2026) & (units) Table 64. Europe Sevoflurane Vaporizer Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Sevoflurane Vaporizer Sales by Application (2021-2026) & (units) Table 66. Asia-Pacific Sevoflurane Vaporizer Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Sevoflurane Vaporizer Sales by Application (2021-2026) & (units) Table 68. Latin America Sevoflurane Vaporizer Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Sevoflurane Vaporizer Sales by Application (2021-2026) & (units) Table 70. Middle East and Africa Sevoflurane Vaporizer Sales by Application (2021-2026) & (US$ Million) Table 71. Dräger Company Information Table 72. Dräger Business Overview Table 73. Dräger Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Dräger Sevoflurane Vaporizer Product Portfolio Table 75. Dräger Recent Development Table 76. GE Healthcare Company Information Table 77. GE Healthcare Business Overview Table 78. GE Healthcare Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. GE Healthcare Sevoflurane Vaporizer Product Portfolio Table 80. GE Healthcare Recent Development Table 81. Mindray Company Information Table 82. Mindray Business Overview Table 83. Mindray Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Mindray Sevoflurane Vaporizer Product Portfolio Table 85. Mindray Recent Development Table 86. Spacelabs Healthcare Company Information Table 87. Spacelabs Healthcare Business Overview Table 88. Spacelabs Healthcare Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Spacelabs Healthcare Sevoflurane Vaporizer Product Portfolio Table 90. Spacelabs Healthcare Recent Development Table 91. Maquet Company Information Table 92. Maquet Business Overview Table 93. Maquet Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Maquet Sevoflurane Vaporizer Product Portfolio Table 95. Maquet Recent Development Table 96. Baxter Company Information Table 97. Baxter Business Overview Table 98. Baxter Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Baxter Sevoflurane Vaporizer Product Portfolio Table 100. Baxter Recent Development Table 101. Oricare Company Information Table 102. Oricare Business Overview Table 103. Oricare Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Oricare Sevoflurane Vaporizer Product Portfolio Table 105. Oricare Recent Development Table 106. STEPHAN Company Information Table 107. STEPHAN Business Overview Table 108. STEPHAN Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. STEPHAN Sevoflurane Vaporizer Product Portfolio Table 110. STEPHAN Recent Development Table 111. Medec Company Information Table 112. Medec Business Overview Table 113. Medec Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Medec Sevoflurane Vaporizer Product Portfolio Table 115. Medec Recent Development Table 116. Foshan Gladent Company Information Table 117. Foshan Gladent Business Overview Table 118. Foshan Gladent Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Foshan Gladent Sevoflurane Vaporizer Product Portfolio Table 120. Foshan Gladent Recent Development Table 121. Hersill Company Information Table 122. Hersill Business Overview Table 123. Hersill Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Hersill Sevoflurane Vaporizer Product Portfolio Table 125. Hersill Recent Development Table 126. Dragerwerk Company Information Table 127. Dragerwerk Business Overview Table 128. Dragerwerk Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Dragerwerk Sevoflurane Vaporizer Product Portfolio Table 130. Dragerwerk Recent Development Table 131. Penlon Company Information Table 132. Penlon Business Overview Table 133. Penlon Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Penlon Sevoflurane Vaporizer Product Portfolio Table 135. Penlon Recent Development Table 136. Nipro Company Information Table 137. Nipro Business Overview Table 138. Nipro Sevoflurane Vaporizer Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Nipro Sevoflurane Vaporizer Product Portfolio Table 140. Nipro Recent Development Table 141. North America Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 142. North America Sevoflurane Vaporizer Sales by Country (2021-2026) & (units) Table 143. North America Sevoflurane Vaporizer Sales Market Share by Country (2021-2026) Table 144. North America Sevoflurane Vaporizer Sales Forecast by Country (2027-2032) & (units) Table 145. North America Sevoflurane Vaporizer Sales Market Share Forecast by Country (2027-2032) Table 146. North America Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Sevoflurane Vaporizer Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Sevoflurane Vaporizer Market Share by Country (2021-2026) Table 149. North America Sevoflurane Vaporizer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Sevoflurane Vaporizer Market Share Forecast by Country (2027-2032) Table 151. Europe Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 152. Europe Sevoflurane Vaporizer Sales by Country (2021-2026) & (units) Table 153. Europe Sevoflurane Vaporizer Sales Market Share by Country (2021-2026) Table 154. Europe Sevoflurane Vaporizer Sales Forecast by Country (2027-2032) & (units) Table 155. Europe Sevoflurane Vaporizer Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Sevoflurane Vaporizer Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Sevoflurane Vaporizer Market Share by Country (2021-2026) Table 159. Europe Sevoflurane Vaporizer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Sevoflurane Vaporizer Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Sevoflurane Vaporizer Sales by Country (2021-2026) & (units) Table 163. Asia-Pacific Sevoflurane Vaporizer Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Sevoflurane Vaporizer Sales Forecast by Country (2027-2032) & (units) Table 165. Asia-Pacific Sevoflurane Vaporizer Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Sevoflurane Vaporizer Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Sevoflurane Vaporizer Market Share by Country (2021-2026) Table 169. Asia-Pacific Sevoflurane Vaporizer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Sevoflurane Vaporizer Market Share Forecast by Country (2027-2032) Table 171. Latin America Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 172. Latin America Sevoflurane Vaporizer Sales by Country (2021-2026) & (units) Table 173. Latin America Sevoflurane Vaporizer Sales Market Share by Country (2021-2026) Table 174. Latin America Sevoflurane Vaporizer Sales Forecast by Country (2027-2032) & (units) Table 175. Latin America Sevoflurane Vaporizer Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Sevoflurane Vaporizer Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Sevoflurane Vaporizer Market Share by Country (2021-2026) Table 179. Latin America Sevoflurane Vaporizer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Sevoflurane Vaporizer Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Sevoflurane Vaporizer Sales by Country (2021-2026) & (units) Table 183. Middle East and Africa Sevoflurane Vaporizer Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Sevoflurane Vaporizer Sales Forecast by Country (2027-2032) & (units) Table 185. Middle East and Africa Sevoflurane Vaporizer Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Sevoflurane Vaporizer Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Sevoflurane Vaporizer Market Share by Country (2021-2026) Table 189. Middle East and Africa Sevoflurane Vaporizer Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Sevoflurane Vaporizer Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Sevoflurane Vaporizer Distributors List Table 194. Sevoflurane Vaporizer Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Sevoflurane Vaporizer Image Figure 2. Global Sevoflurane Vaporizer Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sevoflurane Vaporizer Market Size (2021-2032) & (US$ Million) Figure 4. Global Sevoflurane Vaporizer Sales (2021-2032) & (units) Figure 5. Active Temperature Compensation Image Figure 6. Global Active Temperature Compensation Sales YoY Growth (2021-2032) & (units) Figure 7. Passive Temperature Compensation Image Figure 8. Global Passive Temperature Compensation Sales YoY Growth (2021-2032) & (units) Figure 9. Global Sevoflurane Vaporizer Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Sevoflurane Vaporizer Market Share by Type 2025 VS 2032 Figure 11. North America Sevoflurane Vaporizer Sales Market Share in Volume by Type in 2025 Figure 12. North America Sevoflurane Vaporizer Sales Market Share in Value by Type in 2025 Figure 13. Europe Sevoflurane Vaporizer Sales Market Share in Volume by Type in 2025 Figure 14. Europe Sevoflurane Vaporizer Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Sevoflurane Vaporizer Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Sevoflurane Vaporizer Sales Market Share in Value by Type in 2025 Figure 17. Latin America Sevoflurane Vaporizer Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Sevoflurane Vaporizer Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Sevoflurane Vaporizer Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Sevoflurane Vaporizer Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Sevoflurane Vaporizer Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Surgical Anesthesia Image Figure 24. Global Surgical Anesthesia Sales YoY Growth (2021-2032) & (units) Figure 25. Medical Research Image Figure 26. Global Medical Research Sales YoY Growth (2021-2032) & (units) Figure 27. Animal Anesthesia Image Figure 28. Global Animal Anesthesia Sales YoY Growth (2021-2032) & (units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (units) Figure 31. Global Sevoflurane Vaporizer Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Sevoflurane Vaporizer Market Share by Application 2025 VS 2032 Figure 33. North America Sevoflurane Vaporizer Sales Market Share in Volume by Application in 2025 Figure 34. North America Sevoflurane Vaporizer Sales Market Share in Value by Application in 2025 Figure 35. Europe Sevoflurane Vaporizer Sales Market Share in Volume by Application in 2025 Figure 36. Europe Sevoflurane Vaporizer Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Sevoflurane Vaporizer Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Sevoflurane Vaporizer Sales Market Share in Value by Application in 2025 Figure 39. Latin America Sevoflurane Vaporizer Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Sevoflurane Vaporizer Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Sevoflurane Vaporizer Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Sevoflurane Vaporizer Sales Market Share in Value by Application in 2025 Figure 43. North America Sevoflurane Vaporizer Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 44. North America Sevoflurane Vaporizer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Sevoflurane Vaporizer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Sevoflurane Vaporizer Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sevoflurane Vaporizer Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 48. Europe Sevoflurane Vaporizer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Sevoflurane Vaporizer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Sevoflurane Vaporizer Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Sevoflurane Vaporizer Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 52. Asia-Pacific Sevoflurane Vaporizer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Sevoflurane Vaporizer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Sevoflurane Vaporizer Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Sevoflurane Vaporizer Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 56. Latin America Sevoflurane Vaporizer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Sevoflurane Vaporizer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Sevoflurane Vaporizer Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Sevoflurane Vaporizer Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 60. Middle East and Africa Sevoflurane Vaporizer Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Sevoflurane Vaporizer Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Sevoflurane Vaporizer Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Sevoflurane Vaporizer Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Sevoflurane Vaporizer Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Active Temperature Compensation
  • Passive Temperature Compensation
Applications
  • Surgical Anesthesia
  • Medical Research
  • Animal Anesthesia
  • Others
Companies covered
  • Dräger
  • GE Healthcare
  • Mindray
  • Spacelabs Healthcare
  • Maquet
  • Baxter
  • Oricare
  • STEPHAN
  • Medec
  • Foshan Gladent
  • Hersill
  • Dragerwerk
  • Penlon
  • Nipro

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sevoflurane Vaporizer Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sevoflurane Vaporizer Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sevoflurane Vaporizer Market by Type
  6. 1.3.1 Active Temperature Compensation
  7. 1.3.2 Passive Temperature Compensation
  8. 1.4 Global Sevoflurane Vaporizer Market Size by Type
  9. 1.4.1 Global Sevoflurane Vaporizer Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Sevoflurane Vaporizer Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Sevoflurane Vaporizer Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Sevoflurane Vaporizer Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Sevoflurane Vaporizer Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Sevoflurane Vaporizer Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Sevoflurane Vaporizer Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Sevoflurane Vaporizer Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sevoflurane Vaporizer Industry Trends
  2. 2.2 Sevoflurane Vaporizer Industry Drivers
  3. 2.3 Sevoflurane Vaporizer Industry Opportunities and Challenges
  4. 2.4 Sevoflurane Vaporizer Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sevoflurane Vaporizer Revenue (2021-2026)
  2. 3.2 Global Top Players by Sevoflurane Vaporizer Sales (2021-2026)
  3. 3.3 Global Top Players by Sevoflurane Vaporizer Price (2021-2026)
  4. 3.4 Global Sevoflurane Vaporizer Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sevoflurane Vaporizer Major Company Production Sites & Headquarters
  6. 3.6 Global Sevoflurane Vaporizer Company, Product Type & Application
  7. 3.7 Global Sevoflurane Vaporizer Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sevoflurane Vaporizer Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sevoflurane Vaporizer Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sevoflurane Vaporizer Tier 1, Tier 2, and Tier 3
4 Sevoflurane Vaporizer Regional Status and Outlook
  1. 4.1 Global Sevoflurane Vaporizer Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sevoflurane Vaporizer Historic Market Size by Region
  3. 4.2.1 Global Sevoflurane Vaporizer Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sevoflurane Vaporizer Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sevoflurane Vaporizer Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sevoflurane Vaporizer Forecasted Market Size by Region
  7. 4.3.1 Global Sevoflurane Vaporizer Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sevoflurane Vaporizer Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sevoflurane Vaporizer Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sevoflurane Vaporizer by Application
  1. 5.1 Sevoflurane Vaporizer Market by Application
  2. 5.1.1 Surgical Anesthesia
  3. 5.1.2 Medical Research
  4. 5.1.3 Animal Anesthesia
  5. 5.1.4 Others
  6. 5.2 Global Sevoflurane Vaporizer Market Size by Application
  7. 5.2.1 Global Sevoflurane Vaporizer Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Sevoflurane Vaporizer Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Sevoflurane Vaporizer Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Sevoflurane Vaporizer Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Sevoflurane Vaporizer Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Sevoflurane Vaporizer Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Sevoflurane Vaporizer Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Sevoflurane Vaporizer Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Dräger
  2. 6.1.1 Dräger Company Information
  3. 6.1.2 Dräger Business Overview
  4. 6.1.3 Dräger Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Dräger Sevoflurane Vaporizer Product Portfolio
  6. 6.1.5 Dräger Recent Developments
  7. 6.2 GE Healthcare
  8. 6.2.1 GE Healthcare Company Information
  9. 6.2.2 GE Healthcare Business Overview
  10. 6.2.3 GE Healthcare Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GE Healthcare Sevoflurane Vaporizer Product Portfolio
  12. 6.2.5 GE Healthcare Recent Developments
  13. 6.3 Mindray
  14. 6.3.1 Mindray Company Information
  15. 6.3.2 Mindray Business Overview
  16. 6.3.3 Mindray Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mindray Sevoflurane Vaporizer Product Portfolio
  18. 6.3.5 Mindray Recent Developments
  19. 6.4 Spacelabs Healthcare
  20. 6.4.1 Spacelabs Healthcare Company Information
  21. 6.4.2 Spacelabs Healthcare Business Overview
  22. 6.4.3 Spacelabs Healthcare Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Spacelabs Healthcare Sevoflurane Vaporizer Product Portfolio
  24. 6.4.5 Spacelabs Healthcare Recent Developments
  25. 6.5 Maquet
  26. 6.5.1 Maquet Company Information
  27. 6.5.2 Maquet Business Overview
  28. 6.5.3 Maquet Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Maquet Sevoflurane Vaporizer Product Portfolio
  30. 6.5.5 Maquet Recent Developments
  31. 6.6 Baxter
  32. 6.6.1 Baxter Company Information
  33. 6.6.2 Baxter Business Overview
  34. 6.6.3 Baxter Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Sevoflurane Vaporizer Product Portfolio
  36. 6.6.5 Baxter Recent Developments
  37. 6.7 Oricare
  38. 6.7.1 Oricare Company Information
  39. 6.7.2 Oricare Business Overview
  40. 6.7.3 Oricare Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Oricare Sevoflurane Vaporizer Product Portfolio
  42. 6.7.5 Oricare Recent Developments
  43. 6.8 STEPHAN
  44. 6.8.1 STEPHAN Company Information
  45. 6.8.2 STEPHAN Business Overview
  46. 6.8.3 STEPHAN Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 STEPHAN Sevoflurane Vaporizer Product Portfolio
  48. 6.8.5 STEPHAN Recent Developments
  49. 6.9 Medec
  50. 6.9.1 Medec Company Information
  51. 6.9.2 Medec Business Overview
  52. 6.9.3 Medec Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Medec Sevoflurane Vaporizer Product Portfolio
  54. 6.9.5 Medec Recent Developments
  55. 6.10 Foshan Gladent
  56. 6.10.1 Foshan Gladent Company Information
  57. 6.10.2 Foshan Gladent Business Overview
  58. 6.10.3 Foshan Gladent Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Foshan Gladent Sevoflurane Vaporizer Product Portfolio
  60. 6.10.5 Foshan Gladent Recent Developments
  61. 6.11 Hersill
  62. 6.11.1 Hersill Company Information
  63. 6.11.2 Hersill Business Overview
  64. 6.11.3 Hersill Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hersill Sevoflurane Vaporizer Product Portfolio
  66. 6.11.5 Hersill Recent Developments
  67. 6.12 Dragerwerk
  68. 6.12.1 Dragerwerk Company Information
  69. 6.12.2 Dragerwerk Business Overview
  70. 6.12.3 Dragerwerk Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dragerwerk Sevoflurane Vaporizer Product Portfolio
  72. 6.12.5 Dragerwerk Recent Developments
  73. 6.13 Penlon
  74. 6.13.1 Penlon Company Information
  75. 6.13.2 Penlon Business Overview
  76. 6.13.3 Penlon Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Penlon Sevoflurane Vaporizer Product Portfolio
  78. 6.13.5 Penlon Recent Developments
  79. 6.14 Nipro
  80. 6.14.1 Nipro Company Information
  81. 6.14.2 Nipro Business Overview
  82. 6.14.3 Nipro Sevoflurane Vaporizer Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Nipro Sevoflurane Vaporizer Product Portfolio
  84. 6.14.5 Nipro Recent Developments
7 North America by Country
  1. 7.1 North America Sevoflurane Vaporizer Sales by Country
  2. 7.1.1 North America Sevoflurane Vaporizer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sevoflurane Vaporizer Sales by Country (2021-2026)
  4. 7.1.3 North America Sevoflurane Vaporizer Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sevoflurane Vaporizer Market Size by Country
  6. 7.2.1 North America Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sevoflurane Vaporizer Market Size by Country (2021-2026)
  8. 7.2.3 North America Sevoflurane Vaporizer Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sevoflurane Vaporizer Sales by Country
  2. 8.1.1 Europe Sevoflurane Vaporizer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sevoflurane Vaporizer Sales by Country (2021-2026)
  4. 8.1.3 Europe Sevoflurane Vaporizer Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sevoflurane Vaporizer Market Size by Country
  6. 8.2.1 Europe Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sevoflurane Vaporizer Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sevoflurane Vaporizer Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sevoflurane Vaporizer Sales by Country
  2. 9.1.1 Asia-Pacific Sevoflurane Vaporizer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sevoflurane Vaporizer Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sevoflurane Vaporizer Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sevoflurane Vaporizer Market Size by Country
  6. 9.2.1 Asia-Pacific Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sevoflurane Vaporizer Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sevoflurane Vaporizer Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sevoflurane Vaporizer Sales by Country
  2. 10.1.1 South America Sevoflurane Vaporizer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sevoflurane Vaporizer Sales by Country (2021-2026)
  4. 10.1.3 South America Sevoflurane Vaporizer Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sevoflurane Vaporizer Market Size by Country
  6. 10.2.1 South America Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sevoflurane Vaporizer Market Size by Country (2021-2026)
  8. 10.2.3 South America Sevoflurane Vaporizer Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sevoflurane Vaporizer Sales by Country
  2. 11.1.1 Middle East and Africa Sevoflurane Vaporizer Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sevoflurane Vaporizer Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sevoflurane Vaporizer Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sevoflurane Vaporizer Market Size by Country
  6. 11.2.1 Middle East and Africa Sevoflurane Vaporizer Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sevoflurane Vaporizer Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sevoflurane Vaporizer Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sevoflurane Vaporizer Value Chain Analysis
  2. 12.1.1 Sevoflurane Vaporizer Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sevoflurane Vaporizer Production Mode & Process
  7. 12.2 Sevoflurane Vaporizer Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sevoflurane Vaporizer Distributors
  10. 12.2.3 Sevoflurane Vaporizer Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research